Conclusion and Remarks

Abstract

The accurate diagnosis of bladder cancer along with the proper evaluation of prognostic and predictive factors is critical for pathology practice in bladder diseases and allows for appropriate disease management and increased rates of patient survival. With its high prevalence and an aging population, pathologists will face more bladder cancer cases in the coming years. Differentiating between benign mimickers and other types of malignancy is central to the practice of pathology. Incorporating molecular advances in pathology is the future trend for the practice. This book summarizes pathologic findings with important prognostic factors, including the staging and grading of bladder cancers and the most recent advances in bladder molecular pathology, and serves a tool for practicing pathologists, clinicians, and trainees.